Not all sufferers with CLL demand therapy. In spite of all latest improvements, the iwCLL continue to suggests watchful observation for clients with asymptomatic ailment.86 This advice is predicated on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). "Berdasarkan hasil https://zackg308eov6.estate-blog.com/profile